RPS20P23

Across TCGA pan-cancer cohorts, RPS20P23 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS20P23 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPS20P23 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS20P23 expression acts as an unfavorable survival marker, although some lineages such as OV and LUAD show a favorable association.

KIRC, THCA, and BRCA are the cancer types where RPS20P23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.248	0.665	.002	87	view →
THCA	OS	Tertile	All	0.751	0.954	<.001	54	view →
BRCA	DFS	Tertile	III,IV	0.686	0.889	<.001	36	view →
LGG	OS	Tertile	All	0.464	0.816	<.001	36	view →
MESO	DFS	Tertile	All	0.113	0.485	.003	27	view →
PCPG	OS	Tertile	All	0.010	0.946	<.001	27	view →
READ	DFS	Tertile	III,IV	0.269	0.744	.025	9	view →
OV	OS	Tertile	IV	1.000	0.583	.021	6	view →
LAML	DFS	Tertile	All	0.470	0.602	.035	6	view →
LUAD	DFS	Tertile	II,III,IV	1.000	0.491	.044	6	view →
ESCA	OS	Tertile	All	0.581	0.744	.025	4	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS20P23–KIRC (DFS)

Open the KIRC breakdown →